Login to Your Account



Enthusiasm Renewed

HIV Vaccine Research Gets its Second Wind

By Peter Winter
Editor

Monday, July 30, 2012

Fifteen years have elapsed since the former U.S. president Bill Clinton predicted in 1997 the introduction of a vaccine for AIDS "within a decade." Unfortunately, instead of the prediction becoming a reality, 2007 represented a particularly low point for HIV vaccine research. During that year Merck & Co. Inc. announced that it was discontinuing its HIV vaccine trial. Merck, along with the AIDS community had high hopes for the drug, which had been in development for almost a decade. Its failure caused researchers to become pessimistic about the prospects of ever achieving an effective HIV vaccine in the foreseeable future.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription